This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Sep;7(9):987-9.

doi: 10.1038/nm0901-987.

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

R K Jain¹

Affiliations

Affiliation

¹ Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA. jain@steele.mgh.harvard.edu

PMID: 11533692
DOI: 10.1038/nm0901-987

Review

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

R K Jain. Nat Med. 2001 Sep.

. 2001 Sep;7(9):987-9.

doi: 10.1038/nm0901-987.

Author

R K Jain¹

Affiliation

¹ Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA. jain@steele.mgh.harvard.edu

PMID: 11533692
DOI: 10.1038/nm0901-987

No abstract available

PubMed Disclaimer

Comment in

Recognition of tumor blood vessel normalization as a new antiangiogenic concept.
Hellmann K. Hellmann K. Nat Med. 2004 Apr;10(4):329; author reply 329-30. doi: 10.1038/nm0404-329a. Nat Med. 2004. PMID: 15057218 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov